Ziekenhuisgroep Twente Stichting

Almelo 54 trials 23 recruiting

54 Registered trials

23 Currently recruiting

Organisation

Ziekenhuisgroep Twente Stichting

Location

Almelo, Netherlands

Identifier

ORG-100044112

Address

Zilvermeeuw 1, 7609 PP, Netherlands

Departments

2203: Rheumatology
Cardiology
Department of Medical Oncology
Department of Oncology
Department of Surgery
Gynaecology
Hematology
ICU
Intensive care unit
Internal Medicine
Internal Medicine / Nephrology
Internal Medicine and Gastrointestinal liver disease
Internal Oncology
Interne geneeskunde
Medical Oncology
medische oncologie
N/A
Nephrology
Oncologie
Oncology
Oncology center
Pulmonology
Rheumatology
Surgery
Urology

Clinical trials at this site (54)

Search interface

A randomized, parallel-group, double-blind, placebo-controlled, multicenter Phase III trial to evaluate efficacy and safety of secukinumab a… Ended

2022-501895-25-00 Polymyalgia Rheumatica 5 2023-09-13
A Phase 2, Open-Label, Multi-Center, Randomized Study of TAR-200 in Combination with Cetrelimab and Cetrelimab Alone in Participants with Mu… Ended

2023-507189-17-00 Muscle-Invasive Urothelial Carcinoma of the Bladder 4 2022-01-09
A multi site clinical trial to evaluate the efficacy and safety of Qutenza® in subjects with post-surgical neuropathic pain Ended

2024-514934-19-00 Post-surgical neuropathic pain 5 2021-11-08
Phase 3 Study of Pembrolizumab plus Enzalutamide in mCRPC Ended

2022-500785-10-00 Metastatic Castration-Resistant Prostate Cancer 5 2019-08-23
Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke Ended

2023-503673-38-00 Adults at high risk of cardiovascular events without pr 5 2019-05-24
A safety and efficacy study of ABT-494 in subjects with Giant Cell Arteritis. Ended

2023-505476-29-00 Giant Cell Arteritis 5 2019-04-05